Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03721458 · ClinicalTrials.gov registry record
Whole Genome Sequencing in the Neonatal Intensive Care Unit
A clinical trial, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- 3
- Enrollment target
NCT03721458: Completed study, sponsored by Milton S. Hershey Medical Center.
NCT03721458 is a clinical trial that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03721458 has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- 3 participants
- Enrollment target
Study Summary
This research is being done to see if whole genome sequencing (WGS) improves the diagnosis of patients in the NICU. Using WGS in this way, which is relatively new, researchers at Penn State College of Medicine will look at approximately 5000 genes that are known to be associated with genetic diseases to see if the neonatal patient has a known disease causing mutation. Comparing the parents' DNA with the child's will help the investigators better understand the child's DNA.
Primary Outcome
The investigator will determine the percent of patients for which sequencing provided a correct genetic disease diagnosis, relative to that obtained by standard clinical evaluation.
Interventions
- OTHER Sequence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2019-05-28 |
| Est. Completion | 2020-06-30 |
What the finished NCT03721458 record still lists
NCT03721458 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 3 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Sequence is the first listed.
NCT03721458 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03721458 about?
NCT03721458 is a clinical study titled "Whole Genome Sequencing in the Neonatal Intensive Care Unit". This research is being done to see if whole genome sequencing (WGS) improves the diagnosis of patients in the NICU. Using WGS in this way, which is relatively new, researchers at Penn State College of Medicine will look at approximately 5000 genes that are known to be associated with genetic disease...
What is the current status of trial NCT03721458?
This trial is currently completed. The enrollment target is 3 participants. The study started on 2019-05-28. Estimated completion is 2020-06-30.
What interventions are being tested in trial NCT03721458?
The interventions under investigation include: Sequence (OTHER).
Who is sponsoring clinical trial NCT03721458?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI